Tirzepatide 40mg Injection Pen Kit — Dual GIP / GLP-1 Receptor Agonist

Dual incretin receptor agonist formulated in a high-capacity 40mg pen kit for consistent, reproducible GIP and GLP-1 co-agonism research outcomes.

Analytical Specifications & HPLC Purity

  • Batch ID: SYN-26TZ-3318B (RP-HPLC Purity: 99.48%)
  • CAS / Formula: 2023788-19-2 | C225H348N48O68 (4813.45 g/mol)
  • Format: 4 x 10mg | 1 click = 0.1667 mg
  • Storage: 2°C – 8°C (Refrigerated) | Half-life: ~5 days (120 hours)

Kit Contents

  • 1x Reusable Anodized Synedica 60-Unit Precision Pen
  • 4x 10mg Sterile Pre-Filled Borosilicate Cartridges (40mg total)
  • 12x Ultra-Fine 31G 4mm Siliconized Micro-Needles
  • 12x Sterile 70% Isopropyl Prep Swabs
  • 1x Thermal-Insulated Magnetic Presentation Case & Scratch-Off Security Seal

60-Unit Pen Titration & Click Schedule

WeeksDoseClicksPhase
Weeks 1–42.5 mg / wk15 unitsBaseline Incretin Priming
Weeks 5–85.0 mg / wk30 unitsStandard Dual-Agonist Step
Weeks 9–127.5–10.0 mg / wk45–60 unitsEnhanced Glycemic & Metabolic Phase
Week 13+12.5–15.0 mg / wk75–90 unitsMaximum Protocol Ceiling